Literature DB >> 16831520

A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women.

Rosemarie Krug1, Jan Born, Björn Rasch.   

Abstract

Estrogen secretion in young women follows a cyclic pattern characterized by a pronounced surge in estrogen around ovulation. The way in which this estrogen peak affects cognitive functioning is unclear. Short-term estrogen treatment for a few days mimicking normal pre-menopausal estrogen dynamics substantially enhanced cognitive functions in ovariectomized animals. Here, we provide evidence that inducing a single estrogen peak in postmenopausal women improves their cognitive abilities. Healthy women (51-64 yrs, n=14) received either 100 microg estrogen transdermally for 3 days or placebo in a double-blind within-subject design. The treatment caused a temporary rise in serum estrogen levels roughly comparable to the mid-cyclic changes in estrogen in young women. At the end of the treatment, the women completed two types of tests involving primarily hippocampus-dependent functions of memory retention or prefrontal cortex-dependent functions. Results revealed a clear beneficial effect of estrogen on tasks mainly involving the prefrontal cortex: performance on a digit-ordering task (p<0.05) and on a task requiring short-term memory of event sequences in an unfamiliar story (p<0.01) were improved, and susceptibility to interference in the Stroop test (p<0.05) was diminished after estrogen. On the other hand, estrogen did not affect hippocampus-dependent retention of a story, with delayed recall tested after 30 min or 1 week, although immediate recall was improved by estrogen. We conclude that in postmenopausal women, a transient increase in plasma estrogen concentration acutely improves prefrontal cortex-dependent cognitive functions, whereas hippocampus-dependent memory retention is less affected. Our results encourage future studies to investigate whether repeated induction of short-lasting estrogen peaks could enhance cognitive efficacy of hormonal replacement therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831520     DOI: 10.1016/j.psyneuen.2006.05.007

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  34 in total

1.  Long-term replacement of estrogen in combination with medroxyprogesterone acetate improves acquisition of an alternation task in middle-aged female rats.

Authors:  Nioka C Chisholm; Janice M Juraska
Journal:  Behav Neurosci       Date:  2011-12-05       Impact factor: 1.912

2.  Differential impact of continuous theta-burst stimulation over left and right DLPFC on planning.

Authors:  Christoph P Kaller; Katharina Heinze; Annekathrein Frenkel; Claus H Läppchen; Josef M Unterrainer; Cornelius Weiller; Rüdiger Lange; Benjamin Rahm
Journal:  Hum Brain Mapp       Date:  2011-10-14       Impact factor: 5.038

3.  Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.

Authors:  Paul A Newhouse; Julie Dumas; Heather Wilkins; Emily Coderre; Cynthia K Sites; Magdalena Naylor; Chawki Benkelfat; Simon N Young
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

4.  Effects of long-term treatment with estrogen and medroxyprogesterone acetate on synapse number in the medial prefrontal cortex of aged female rats.

Authors:  Nioka C Chisholm; Janice M Juraska
Journal:  Menopause       Date:  2012-07       Impact factor: 2.953

Review 5.  Estrogen-cholinergic interactions: Implications for cognitive aging.

Authors:  Paul Newhouse; Julie Dumas
Journal:  Horm Behav       Date:  2015-07-14       Impact factor: 3.587

Review 6.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

7.  Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease.

Authors:  Whitney Wharton; Carey E Gleason; Katelin R Lorenze; Tamara S Markgraf; Michele L Ries; Cynthia M Carlsson; Sanjay Asthana
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

Review 8.  Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.

Authors:  Mohammad M Khan
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

9.  Neuroprotective actions of selective estrogen receptor modulators.

Authors:  Lydia L DonCarlos; Iñigo Azcoitia; Luis M Garcia-Segura
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

10.  Executive functions and selective attention are favored in middle-aged healthy women carriers of the Val/Val genotype of the catechol-o-methyltransferase gene: a behavioral genetic study.

Authors:  Silvia Solís-Ortiz; Elva Pérez-Luque; Lisette Morado-Crespo; Mayra Gutiérrez-Muñoz
Journal:  Behav Brain Funct       Date:  2010-10-29       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.